Federal Way, WA, United States of America

Jean-Francois Lucien Maisonneuve

USPTO Granted Patents = 3 

Average Co-Inventor Count = 6.5

ph-index = 2

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2005-2017

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Jean-Francois Lucien Maisonneuve

Introduction

Jean-Francois Lucien Maisonneuve is a notable inventor based in Federal Way, WA (US). He has made significant contributions to the field of immunology, particularly in vaccine development. With a total of three patents to his name, his work has the potential to impact public health positively.

Latest Patents

One of his latest patents is for a selectively disrupted whole-cell vaccine. This invention provides immunogenic compositions and methods for producing an immunogenic composition with multiple immunity-inducing fractions of killed, whole cells. By selectively disrupting a whole cell bacterial preparation, the invention ensures that both a soluble fraction, which induces a primarily antibody response, and a cellular fraction, which induces a primarily antibody-independent response, remain in the immunogenic composition. Another significant patent relates to vaccines against chlamydial infection. This invention comprises proteins or polynucleotides of specific strains, particularly combinations of proteins or polynucleotides encoding them, and methods for their use in the treatment, prevention, and diagnosis of infection.

Career Highlights

Throughout his career, Jean-Francois has worked with prominent companies in the biotechnology sector, including Corixa Corporation and GlaxoSmithKline Biologicals SA. His experience in these organizations has allowed him to develop and refine his innovative ideas in vaccine technology.

Collaborations

He has collaborated with notable professionals in his field, including Ajay Bhatia and Mark R. Alderson. These collaborations have likely contributed to the advancement of his research and the successful development of his patents.

Conclusion

Jean-Francois Lucien Maisonneuve is a distinguished inventor whose work in vaccine development showcases his commitment to improving public health. His innovative patents reflect his expertise and dedication to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…